Global Genomics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genomics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genomics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Instruments
  • 1.4.3 Consumables
  • 1.4.4 Services
• 1.5 Market by Application
  • 1.5.1 Global Genomics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Research Institutes
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genomics Market Perspective (2015-2026)
• 2.2 Global Genomics Growth Trends by Regions
  • 2.2.1 Genomics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genomics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genomics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genomics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genomics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genomics Players by Market Size
  • 3.1.1 Global Top Genomics Players by Revenue (2015-2020)
  • 3.1.2 Global Genomics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genomics Market Concentration Ratio
  • 3.2.1 Global Genomics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genomics Revenue in 2019
• 3.3 Genomics Key Players Head office and Area Served
• 3.4 Key Players Genomics Product Solution and Service
• 3.5 Date of Enter into Genomics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genomics Historic Market Size by Type (2015-2020)
• 4.2 Global Genomics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genomics Market Size by Application (2015-2020)
• 5.2 Global Genomics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genomics Market Size (2015-2020)
• 6.2 Genomics Key Players in North America (2019-2020)
• 6.3 North America Genomics Market Size by Type (2015-2020)
• 6.4 North America Genomics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genomics Market Size (2015-2020)
• 7.2 Genomics Key Players in Europe (2019-2020)
• 7.3 Europe Genomics Market Size by Type (2015-2020)
• 7.4 Europe Genomics Market Size by Application (2015-2020)

8 China

• 8.1 China Genomics Market Size (2015-2020)
• 8.2 Genomics Key Players in China (2019-2020)
• 8.3 China Genomics Market Size by Type (2015-2020)
• 8.4 China Genomics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genomics Market Size (2015-2020)
• 9.2 Genomics Key Players in Japan (2019-2020)
• 9.3 Japan Genomics Market Size by Type (2015-2020)
• 9.4 Japan Genomics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genomics Market Size (2015-2020)
• 10.2 Genomics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genomics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genomics Market Size by Application (2015-2020)

11 India

• 11.1 India Genomics Market Size (2015-2020)
• 11.2 Genomics Key Players in India (2019-2020)
• 11.3 India Genomics Market Size by Type (2015-2020)
• 11.4 India Genomics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genomics Market Size (2015-2020)
• 12.2 Genomics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genomics Market Size by Type (2015-2020)
• 12.4 Central & South America Genomics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina Inc
  • 13.1.1 Illumina Inc Company Details
  • 13.1.2 Illumina Inc Business Overview
  • 13.1.3 Illumina Inc Genomics Introduction
  • 13.1.4 Illumina Inc Revenue in Genomics Business (2015-2020))
  • 13.1.5 Illumina Inc Recent Development
• 13.2 Agilent Technologies
  • 13.2.1 Agilent Technologies Company Details
  • 13.2.2 Agilent Technologies Business Overview
  • 13.2.3 Agilent Technologies Genomics Introduction
  • 13.2.4 Agilent Technologies Revenue in Genomics Business (2015-2020)
  • 13.2.5 Agilent Technologies Recent Development
• 13.3 Roche Diagnostics
  • 13.3.1 Roche Diagnostics Company Details
  • 13.3.2 Roche Diagnostics Business Overview
  • 13.3.3 Roche Diagnostics Genomics Introduction
  • 13.3.4 Roche Diagnostics Revenue in Genomics Business (2015-2020)
  • 13.3.5 Roche Diagnostics Recent Development
• 13.4 Cancer Genetics Inc
  • 13.4.1 Cancer Genetics Inc Company Details
  • 13.4.2 Cancer Genetics Inc Business Overview
  • 13.4.3 Cancer Genetics Inc Genomics Introduction
  • 13.4.4 Cancer Genetics Inc Revenue in Genomics Business (2015-2020)
  • 13.4.5 Cancer Genetics Inc Recent Development
• 13.5 Bio-Rad Laboratories
  • 13.5.1 Bio-Rad Laboratories Company Details
  • 13.5.2 Bio-Rad Laboratories Business Overview
  • 13.5.3 Bio-Rad Laboratories Genomics Introduction
  • 13.5.4 Bio-Rad Laboratories Revenue in Genomics Business (2015-2020)
  • 13.5.5 Bio-Rad Laboratories Recent Development
• 13.6 Sigma Aldrich
  • 13.6.1 Sigma Aldrich Company Details
  • 13.6.2 Sigma Aldrich Business Overview
  • 13.6.3 Sigma Aldrich Genomics Introduction
  • 13.6.4 Sigma Aldrich Revenue in Genomics Business (2015-2020)
  • 13.6.5 Sigma Aldrich Recent Development
• 13.7 Qiagen
  • 13.7.1 Qiagen Company Details
  • 13.7.2 Qiagen Business Overview
  • 13.7.3 Qiagen Genomics Introduction
  • 13.7.4 Qiagen Revenue in Genomics Business (2015-2020)
  • 13.7.5 Qiagen Recent Development
• 13.8 Perkin Elmer
  • 13.8.1 Perkin Elmer Company Details
  • 13.8.2 Perkin Elmer Business Overview
  • 13.8.3 Perkin Elmer Genomics Introduction
  • 13.8.4 Perkin Elmer Revenue in Genomics Business (2015-2020)
  • 13.8.5 Perkin Elmer Recent Development
• 13.9 Affymetrix
  • 13.9.1 Affymetrix Company Details
  • 13.9.2 Affymetrix Business Overview
  • 13.9.3 Affymetrix Genomics Introduction
  • 13.9.4 Affymetrix Revenue in Genomics Business (2015-2020)
  • 13.9.5 Affymetrix Recent Development
• 13.10 GE Healthcare
  • 13.10.1 GE Healthcare Company Details
  • 13.10.2 GE Healthcare Business Overview
  • 13.10.3 GE Healthcare Genomics Introduction
  • 13.10.4 GE Healthcare Revenue in Genomics Business (2015-2020)
  • 13.10.5 GE Healthcare Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer